Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NEULANDLAB | NSE
-282.00
-1.86%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
21/04/2026
14,920.00
15,250.00
15,491.00
14,848.00
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India Europe the United States and internationally. The company's APIs are used in various therapeutic areas including antiasthmatics cardiovasculars antifungal anticonvulsants central nervous system fluoroquinolones antipsychotic antibacterial and anti-parkinson. It also provides custom manufacturing solutions as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad India.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
High Short-term Volatility
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
47.5%1 month
49.4%3 months
47.0%6 months
41.5%53.76
18.45
14.09
0.07
0.05
34.57
11.33
-
4.84B
209.50B
2.24B
0.10
24.36
58.20
21.10
26.36
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.46K
Range1M
3.99K
Range3M
3.99K
Rel. volume
0.67
Price X volume
460.74M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Wockhardt Limited | WOCKPHARMA | Drug Manufacturers-Specialty & Generic | 1407.7 | 215.97B | 0.30% | n/a | 70.14% |
| AstraZeneca Pharma India Limited | ASTRAZEN | Drug Manufacturers-Specialty & Generic | 8452 | 211.30B | -0.93% | 197.18 | 0.65% |
| Dr. Reddy's Laboratories Limited | DRREDDY | Drug Manufacturers-Specialty & Generic | 1220.6 | 203.34B | -0.97% | 20.23 | 10.41% |
| Piramal Pharma Limited | PPLPHARMA | Biotechnology | 150.81 | 199.37B | 1.36% | 805.68 | 59.54% |
| NATCO Pharma Limited | NATCOPHARM | Drug Manufacturers-Specialty & Generic | 1055.65 | 189.08B | -4.04% | 15.31 | 6.34% |
| Eris Lifesciences Limited | ERIS | Drug Manufacturers-Specialty & Generic | 1376 | 187.55B | -3.94% | 48.08 | 107.55% |
| Syngene International Limited | SYNGENE | Biotechnology | 444.65 | 178.39B | 1.88% | 71.45 | 13.66% |
| Granules India Limited | GRANULES | Drug Manufacturers-Specialty & Generic | 667.75 | 161.84B | 0.50% | 29.41 | 40.77% |
| Alembic Pharmaceuticals Limited | APLLTD | Drug Manufacturers-Specialty & Generic | 764.3 | 153.15B | 0.90% | 36.23 | 10.65% |
| Jubilant Pharmova Limited | JUBLPHARMA | Drug Manufacturers-Specialty & Generic | 906.95 | 141.58B | 0.16% | 33.46 | 67.43% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| AFFLE | AFFLE | Advertising Agencies | 1462.9 | 204.59B | 1.25% | 67.64 | 7.31% |
| Vedant Fashions Limited | MANYAVAR | Apparel Retail | 450.85 | 110.28B | 0.48% | 84.26 | 27.74% |
| Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 50.53 | 44.32B | -5.04% | 48.67 | 10.74% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 271.87 | 15.94B | 0.54% | 30.54 | 80.30% |
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 100.64 | 14.83B | -0.92% | 28.83 | 43.67% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 197.59 | 7.05B | 3.12% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 214.72 | 6.94B | -0.03% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 61 | 1.68B | -1.98% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 93.13 | 1.35B | 1.38% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 74.4 | 829.47M | -0.24% | 50.06 | 4.88% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 34.57 | 24.85 | Expensive |
| Ent. to Revenue | 11.33 | 11.40 | Par |
| PE Ratio | 53.76 | 51.36 | Par |
| Price to Book | 14.09 | 6.83 | Expensive |
| Dividend Yield | 0.10 | 0.52 | Poor |
| Std. Deviation (3M) | 46.98 | 42.17 | Par |
| Debt to Equity | 0.07 | 0.35 | Cheaper |
| Debt to Assets | 0.05 | 0.17 | Cheaper |
| Market Cap | 209.50B | 290.82B | Emerging |